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Metachronous Intraductal Papillary Neoplasm
of the Bile Duct and Intraductal Papillary Mucinous
Neoplasm of the Pancreas in a Patient Diagnosed
With Mucinous Adenocarcinoma
Gregory T. Brennan, MD1, and John G. Lee, MD1
1Division of Gastroenterology and Hepatology, University of California Irvine Health, Orange, CA
ABSTRACT
Intraductal papillary neoplasmof the bile duct (IPNB) is a rare biliary tumor, which shares some radiologic and histologic similarities
with pancreatic intraductal papillary mucinous neoplasm (IPMN). IPNB is a recognized precursor lesion of invasive adenocarci-
noma.We present a case ofmetachronous IPNB and IPMN lesions in a patient withmucinous adenocarcinoma of the pancreas who
presented with jaundice and abdominal pain. The patient was treated with surgery and adjuvant chemotherapy.
INTRODUCTION
Pancreatic cysts such as intraductal papillary mucinous neoplasms (IPMNs) are often detected incidentally on abdominal imaging.
Up to 38%–68% of IPMNs harbor high-grade dysplasia or pancreatic cancer.1 Similarly, intraductal papillary neoplasm of the bile
duct (IPNB) is a rare biliary tumor characterized by mucin-secreting papillary and/or cystic lesions of the bile ducts.2,3 IPNBs were
only recently distinguished as a separate pathologic entity by theWorld Health Organization in 2010.4 As its name suggests, IPNBs
share some radiologic and histologic similarities with pancreatic IPMNs.
CASE REPORT
A 64-year-old white man with a history of main duct IPMN and remote prostate cancer status after prostatectomy presented to the
emergency department with progressive generalized abdominal pain radiating to the back and jaundice for 2 weeks. This was
associated with fatigue and 20 pounds of unintentional weight loss over the preceding 6 months.
Four years previously, the patient had an endoscopic ultrasound (EUS) for evaluation of an incidental ﬁnding on computed
tomography (CT) showing pancreatic ductal dilation. EUS showed a 2.8-cm cystic lesion in the head of the pancreas in commu-
nication with the main pancreatic duct and upstreammain pancreatic duct dilation measuring 3 mm in the body and 1.7 mm in the
tail. There was a mucin plug at the pancreatic oriﬁce seen endoscopically. The biliary tree was normal. He was diagnosed with main
duct IPMN and was referred for surgical resection, which he declined. The patient was subsequently lost to follow-up until the
present encounter 4 years later.
The patient presented to the emergency department with normal vital signs. Examination was signiﬁcant for jaundice, scleral icterus,
and mild epigastric tenderness. Albumin was 2.5 g/dL, alkaline phosphatase 404 U/L, total bilirubin 20.5 mg/dL, alanine amino-
transferase 131 U/L, aspartate aminotransferase 86 U/L, and normal lipase. Abdominal CT showed new severe intrahepatic and
extrahepatic biliary ductal dilatation and marked increased dilatation of the pancreatic duct (measuring 4.2 cm at the head of the
pancreas). There was expansion of the pancreatic head secondary to multiple dilated and tubular cystic foci, consistent with interval
growth of the previous main duct IPMN.
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EUS and endoscopic retrograde cholangiopancreatography were
performed. EUS revealed massive extrahepatic biliary dilation
up to the common hepatic duct (Figure 1). The pancreatic duct
wasmassively dilated, consistent with previous main duct IPMN
nowwith a newmural nodule seen in themain duct. Endoscopic
retrograde cholangiopancreatography showed a gaping biliary
oriﬁce (“ﬁsh mouth”) ﬁlled with mucin, which was new com-
pared with endoscopy 4 years earlier. The pancreatic oriﬁce was
covered by a polypoid nodule (Figure 2). Biopsies from both
oriﬁces were taken. The pancreatic oriﬁce nodule pathology
was intestinal-type papillary mucinous neoplasm with focal
high-grade dysplasia. Immunohistochemistry from the biliary
oriﬁce was positive for MUC5AC and MUC2, consistent with
intestinal-type IPNB (Figure 3). These ﬁndings were consistent
with metachronous IPNB of the bile duct and IPMN of the
pancreatic duct.
Evaluation for metastatic disease with pancreatic protocol ab-
dominal and chest CT was negative, and the patient underwent
attemptedWhipple resection. Surgery showed amixed cystic and
solid pancreatic head mass 3 cm in size extending into the porta
hepatis and involving the left hepatic artery. Frozen-section
specimens from the head of the pancreas and an adjacent lymph
node revealed mucinous adenocarcinoma of pancreatic origin.
Palliative gastrojejunostomy and choledochojejunostomy were
performed because of local invasion and concern that abundant
mucin in the bile duct could cause obstructive jaundice and
cholangitis. Thepatient recovereduneventfully and later received
palliative chemotherapy with FOLFIRINOX.
DISCUSSION
IPNB is a rare tumor characterized by intraductal papillary
growth that can develop anywhere along the biliary tree. Mucin
hypersecretion and biliary dilation can be seen. Clinically, IPNB
can present in several ways including asymptomatic biliary
dilation seen incidentally on cross-sectional imaging, elevated
liver chemistries, cholangitis or obstructive jaundice from tu-
mor growth, or evenmucin plugging.Microscopically, papillary
fronds with vascular cores are seen. The pathogenesis is not
entirely clear, but most studies come from Japan, China, Korea,
and Taiwan involving Asian patients with associated hep-
atolithiasis and clonorchiasis.5 Only approximately 11% of
reported cases have come from theUnited States.5,6 IPNB ismost
commonly seen in male patients between ages 50 and 70 years.7
IPNB has been considered similar to IPMN of the pancreas be-
cause of its intraductal papillary growth pattern andmicroscopic
features such as mucin secretion.7,8 Despite similarities, IPNBs
and IPMNs are distinct diseases, and recently, these differences
have been delineated. Some now divide IPNB lesions into 2
Figure 1. Endoscopic ultrasound image of a dilated common bile
duct with mucin (arrow points to the dilated CBD with echogenic
material representing intraductal mucin).
Figure 2. A patulous “fish mouth” ampulla with extruding mucin
from the biliary orifice (small arrow) and an adjacent nodule at the
pancreatic orifice (large arrow) seen on endoscopy.
Figure 3. Microscopic findings of papillary mucinous neoplasm of
the bile duct (hematoxylin and eosin stain, 1003).
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subtypes based on histology, with type 1 being most similar to
IPMN and type 2 having higher histopathological grade and
more extensive stromal invasion than IPMN.11 Mucin secretion
is more common in IPMN lesions.8,11 Both IPNB and IPMN
lesions carry risk of progression to carcinoma.8 All surgical
candidates should undergo resection of IPNB lesions because of
concern for higher risk of malignancy in IPNB compared with
IPMN.8 In most series, the risk of IPNB lesions containing car-
cinoma is .50%, but risk factors for malignant progression of
IPNB are not well deﬁned.8 In the absence of consensus guide-
lines for IPNB, it may be reasonable to extrapolate guidelines of
pancreatic cysts to determine higher-risk patients with IPNB
requiring multidisciplinary care.
Our patient has some interesting ﬁndings worth discussion. The
time course is important because he initially presented with
a main duct IPMN and a normal biliary tree, which rules out
a synchronous IPNB. Because the patient had separate biliary and
pancreatic oriﬁces, we felt that local invasion was unlikely in the
absence of endoscopically visible contiguous spread.10 The pa-
thology from separate endoscopic biopsies of the oriﬁces showed
2distinct lesions. It is alsounlikely that the IPNBwasmetastasized
from the preexisting IPMN because of the separate oriﬁces and
the distinct pathology of the lesions. Therefore, he was diagnosed
with metachronous IPMN and IPNB lesions. To our knowledge,
there is 1 reported case of synchronous IPNB and IPMN lesions
and no reported cases of metachronous lesions.9 In summary, we
present a case of metachronous IPNB and IPMN lesions in a pa-
tient with mucinous adenocarcinoma of the pancreas.
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